Letrozole

Overview

Letrozole is an oral non-steroidal aromatase inhibitor used in the treatment of hormonally-responsive breast cancer after surgery. It lowers estrogen levels in postmenopausal women, slowing the growth of certain types of breast tumors that are estrogen-dependent.

API suppliers (33)

Suppliers of Letrozole backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• TAPI NL BV2 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• Natco PharmaIndia1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• Natco PharmaIndia1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• Natco PharmaIndia1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• SHILPA PHARMA LIFESCIENCES LTD1 active DMF
• Cipla USA, Inc.USA1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• SYNTHOKEM LABS PRIVATE LTDIndia1 active DMF
• Natco PharmaIndia1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• Cipla USA, Inc.USA1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• SYNTHOKEM LABS PRIVATE LTDIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Hetero Labs LimitedIndia1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China
• MAC CHEM PRODUCTS INDIA PVT LTD
• TAI HENG INDUSTRY CO LTD

Showing 25 of 33 suppliers — see the full list in the app.

Chemical identity

IUPAC name

4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile

Canonical SMILES

C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3

InChIKey

HPJKCIUCZWXJDR-UHFFFAOYSA-N

Therapeutic areas